$0.0078
0.0018[29.67%]
At close: Apr 24
Better Therapeutics
(OTCPK:BTTX)Better Therapeutics Stock (OTC:BTTX), Analyst Ratings, Price Targets, Predictions
Better Therapeutics Inc has a consensus price target of $4, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from Lake Street, Chardan Capital, and Lake Street on August 10, 2023, August 10, 2023, and April 14, 2023. With an average price target of $5.67 between Lake Street, Chardan Capital, and Lake Street, there's an implied 72736.33% upside for Better Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Lake Street
Chardan Capital
Cowen & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Better Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 08/10/2023 | BTTX | Buy Now | Better Therapeutics | $0.01 | 38460.41% | Lake Street | Thomas Flaten | $5 → $3 | Maintains | Buy | Get Alert |
| 08/10/2023 | BTTX | Buy Now | Better Therapeutics | $0.01 | 115581.23% | Chardan Capital | Keay Nakae | → $9 | Reiterates | Buy → Buy | Get Alert |
| 04/14/2023 | BTTX | Buy Now | Better Therapeutics | $0.01 | 64167.35% | Lake Street | Thomas Flaten | $6 → $5 | Maintains | Buy | Get Alert |
| 03/31/2023 | BTTX | Buy Now | Better Therapeutics | $0.01 | 115581.23% | Chardan Capital | Keay Nakae | $14 → $9 | Maintains | Buy | Get Alert |
| 11/15/2022 | BTTX | Buy Now | Better Therapeutics | $0.01 | 179848.59% | Chardan Capital | Keay Nakae | $17 → $14 | Maintains | Buy | Get Alert |
| 07/29/2022 | BTTX | Buy Now | Better Therapeutics | $0.01 | 218409% | Chardan Capital | Keay Nakae | $15 → $17 | Maintains | Buy | Get Alert |
| 03/16/2022 | BTTX | Buy Now | Better Therapeutics | $0.01 | 231262.47% | Chardan Capital | Keay Nakae | $17 → $18 | Maintains | Buy | Get Alert |
| 11/24/2021 | BTTX | Buy Now | Better Therapeutics | $0.01 | 218409% | Chardan Capital | Keay Nakae | — | Initiates | → Buy | Get Alert |
| 11/10/2021 | BTTX | Buy Now | Better Therapeutics | $0.01 | — | Cowen & Co. | Charles Rhyee | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Better Therapeutics (BTTX)?
The latest price target for Better Therapeutics (OTCPK: BTTX) was reported by Lake Street on August 10, 2023. The analyst firm set a price target for $3.00 expecting BTTX to rise to within 12 months (a possible 38460.41% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Better Therapeutics (BTTX)?
The latest analyst rating for Better Therapeutics (OTCPK: BTTX) was provided by Lake Street, and Better Therapeutics maintained their buy rating.
When was the last upgrade for Better Therapeutics (BTTX)?
There is no last upgrade for Better Therapeutics.
When was the last downgrade for Better Therapeutics (BTTX)?
There is no last downgrade for Better Therapeutics.
When is the next analyst rating going to be posted or updated for Better Therapeutics (BTTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Better Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Better Therapeutics was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
Is the Analyst Rating Better Therapeutics (BTTX) correct?
While ratings are subjective and will change, the latest Better Therapeutics (BTTX) rating was a maintained with a price target of $5.00 to $3.00. The current price Better Therapeutics (BTTX) is trading at is $0.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.